CD4 and pulmonary arterial hypertension: Following the identification of a CD4+ human ventricular cardiac fibroblast (hVCF) subpopulation in vitro using mass cytometry, we determined the clinical relevance of this population by mapping the distribution and expression of αSMA+CD4+ cells in autopsy specimens of patients diagnosed with RV fibrosis and PAH.